Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Fidler

Showing results (141-150 of 288) with videos related to

Pageof 29
Sort By:
Plos One|October 3, 2013
Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failureSara Lodi, Andrew Phillips, Sarah Fidler, et al.
The Journal of Experimental Medicine|October 28, 2024
Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infectionWeiwei Sun, Ce Gao, Gregory Takashi Gladkov, et al.
AIDS Research and Therapy|March 7, 2025
A survey weighted analysis of HPTN 071 (PopART) primary outcome of HIV incidenceTimothy M Skalland, Jean de Dieu Tapsoba, Sahar Z Zangeneh, et al.
HIV Medicine|February 25, 2025
High-risk human papillomavirus prevalence and serostatus in a cohort of cisgender women and people with a cervix living with perinatally acquired HIVMerle Henderson, Dierdre Lyons, Simon Beddows, et al.
Journal of Neurovirology|December 7, 2021
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA studyJasmini Alagaratnam, Davide De Francesco, Henrik Zetterberg, et al.
Journal of the International AIDS Society|January 10, 2022
Closing the gap: did delivery approaches complementary to home-based testing reach men with HIV testing services during and after the HPTN 071 (PopART) trial in Zambia?Mwelwa Muleba Phiri, Ab Schaap, Musonda Simwinga, et al.
Reproductive Health|June 20, 2023
Does distribution of menstrual products through community-based, peer-led sexual and reproductive health services increase use of appropriate menstrual products? Findings from the Yathu Yathu trialBernadette Hensen, Melleh Gondwe, Mwelwa Phiri, et al.
HIV Research & Clinical Practice|September 8, 2024
A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnTGary Whitlock, Sarah Fidler, Amanda Clarke, et al.
Frontiers in Immunology|August 24, 2019
Maintenance of Functional CD57+ Cytolytic CD4+ T Cells in HIV+ Elite ControllersChansavath Phetsouphanh, Daniel Aldridge, Emanuele Marchi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2019
Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South AfricaGeoffrey Fatti, Ashraf Grimwood, Jean B Nachega, et al.
Pageof 29

Showing results (141-150 of 288) with videos related to

Sort By:
Pageof 29
Plos One|October 3, 2013
Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failureSara Lodi, Andrew Phillips, Sarah Fidler, et al.
The Journal of Experimental Medicine|October 28, 2024
Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infectionWeiwei Sun, Ce Gao, Gregory Takashi Gladkov, et al.
AIDS Research and Therapy|March 7, 2025
A survey weighted analysis of HPTN 071 (PopART) primary outcome of HIV incidenceTimothy M Skalland, Jean de Dieu Tapsoba, Sahar Z Zangeneh, et al.
HIV Medicine|February 25, 2025
High-risk human papillomavirus prevalence and serostatus in a cohort of cisgender women and people with a cervix living with perinatally acquired HIVMerle Henderson, Dierdre Lyons, Simon Beddows, et al.
Journal of Neurovirology|December 7, 2021
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA studyJasmini Alagaratnam, Davide De Francesco, Henrik Zetterberg, et al.
Journal of the International AIDS Society|January 10, 2022
Closing the gap: did delivery approaches complementary to home-based testing reach men with HIV testing services during and after the HPTN 071 (PopART) trial in Zambia?Mwelwa Muleba Phiri, Ab Schaap, Musonda Simwinga, et al.
Reproductive Health|June 20, 2023
Does distribution of menstrual products through community-based, peer-led sexual and reproductive health services increase use of appropriate menstrual products? Findings from the Yathu Yathu trialBernadette Hensen, Melleh Gondwe, Mwelwa Phiri, et al.
HIV Research & Clinical Practice|September 8, 2024
A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnTGary Whitlock, Sarah Fidler, Amanda Clarke, et al.
Frontiers in Immunology|August 24, 2019
Maintenance of Functional CD57+ Cytolytic CD4+ T Cells in HIV+ Elite ControllersChansavath Phetsouphanh, Daniel Aldridge, Emanuele Marchi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2019
Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South AfricaGeoffrey Fatti, Ashraf Grimwood, Jean B Nachega, et al.
Pageof 29